Emdormi Rymbai

5PUBLICATIONS
7CO-AUTHORS
AutoimmunityPharmaceutical delivery technologiesPsychology of ageingToxicology (incl. clinical toxicology)Clinical pharmacology and therapeutics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 24, 2024
Roflumilast-loaded nanostructured lipid carriers attenuate oxidative stress and neuroinflammation in Parkinson's disease model.

Dhritiman Roy, Shivaramakrishnan Balasubramanian, Prajwal P Kunte

|Apr 15, 2024
Molecular insights into the potential effects of selective estrogen receptor β agonists in Alzheimer's and Parkinson's diseases.

Emdormi Rymbai, Deepa Sugumar, Amritha Chakkittukandiyil

|Jan 25, 2024
The identification of c-Abl inhibitors as potential agents for Parkinson's disease: a preliminary in silico approach.

Emdormi Rymbai, Dhritiman Roy, Srikanth Jupudi

|Apr 19, 2023
Phosphodiesterase-4 Inhibition in Parkinson's Disease: Molecular Insights and Therapeutic Potential.

Dhritiman Roy, Shivaramakrishnan Balasubramanian, Praveen Thaggikuppe Krishnamurthy

Pageof 1